The longevity and efficiency of Invivofectamine 3.0 as a means to deliver nucleic acid for developing treatments for Age-Related Macular Degeneration

  • Natoli, Riccardo (PI)
  • Chu-Tan, Joshua (CoI)
  • Provis, Jan (CoI)
  • Rutar, Matthew (CoI)
  • Saxena, Kartik (CoI)

    Project: Research

    Project Details

    StatusFinished
    Effective start/end date6/11/155/05/16

    Funding

    • Thermo Fisher Scientific Inc: A$7,149.00